<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" nameag="viewport"/>
<title>Drugs For Dyslipidemia</title>
<script src="https://cdn.tailwindcss.com"></script>
<script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
<script src="https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js"></script>
<style>
        /* Custom styles for enhanced aesthetics and responsiveness */
        .option-btn {
            transition: all 0.3s ease;
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
        }
        .option-btn:hover, .option-btn:active {
            transform: scale(1.02);
            box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
        }
        .option-btn.selected {
            background-color: #3b82f6;
            color: white;
        }
        .marked {
            background-color: #fef08a;
        }
        .progress-bar {
            transition: width 0.5s ease-in-out;
            background: linear-gradient(to right, #3b82f6, #22c55e);
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
            animation: pulse 2s infinite;
        }
        @keyframes pulse {
            0% { opacity: 1; }
            50% { opacity: 0.8; }
            100% { opacity: 1; }
        }
        .question-nav-btn, .result-nav-btn-grid {
            width: 40px;
            height: 40px;
            display: flex;
            align-items: center;
            justify-content: center;
            border-radius: 8px;
            font-size: 16px;
            touch-action: manipulation;
            transition: all 0.2s ease;
        }
        .question-nav-btn:hover, .question-nav-btn:active, .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
            transform: scale(1.05);
        }
        .answered {
            background-color: #22c55e;
            color: white;
        }
        .unanswered {
            background-color: #e5e7eb;
        }
        .marked-nav {
            border: 2px solid #fef08a;
        }
        .video-container, .audio-container {
            display: none;
            position: relative;
        }
        .video-container.active, .audio-container.active {
            display: block;
            animation: fadeIn 0.5s ease-in;
        }
        @keyframes fadeIn {
            from { opacity: 0; }
            to { opacity: 1; }
        }
        .section-transition {
            transition: opacity 0.3s ease;
        }
        .section-transition.hidden {
            opacity: 0;
            pointer-events: none;
        }
        .result-nav {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-top: 1rem;
        }
        .result-nav-btn {
            background-color: #4b5563;
            color: white;
            padding: 0.5rem 1rem;
            border-radius: 8px;
            transition: all 0.2s ease;
        }
        .result-nav-btn:hover, .result-nav-btn:active {
            background-color: #374151;
            transform: scale(1.05);
        }
        .result-nav-btn:disabled {
            background-color: #d1d5db;
            cursor: not-allowed;
        }
        .error-message {
            color: #dc2626;
            font-weight: bold;
            margin-top: 1rem;
        }
        /* Mobile-specific adjustments */
        @media (max-width: 640px) {
            .question-nav-btn, .result-nav-btn-grid {
                width: 38px;
                height: 38px;
                font-size: 14px;
            }
            .nav-panel, .results-nav-panel {
                width: 100%;
                max-width: 100%;
                overscroll-behavior: contain;
            }
            .option-btn {
                padding: 12px;
                font-size: 14px;
            }
            .header-text {
                font-size: 1.5rem;
            }
            .subheader-text {
                font-size: 0.875rem;
            }
            .button-group, .result-nav {
                flex-direction: column;
                gap: 0.5rem;
            }
            .result-nav-btn {
                width: 100%;
                text-align: center;
            }
        }
        /* Dark mode styles */
        .dark .bg-gray-100 {
            background-color: #1f2937;
        }
        .dark .bg-white {
            background-color: #374151;
        }
        .dark .text-gray-700 {
            color: #d1d5db;
        }
        .dark .text-gray-800 {
            color: #e5e7eb;
        }
        .dark .bg-gray-200 {
            background-color: #4b5563;
        }
        .dark .border {
            border-color: #4b5563;
        }
        .dark .bg-blue-500 {
            background-color: #2563eb;
        }
        .dark .hover\:bg-blue-600:hover {
            background-color: #1d4ed8;
        }
        .dark .bg-yellow-300 {
            background-color: #b45309;
            color: white;
        }
        .dark .hover\:bg-yellow-400:hover {
            background-color: #92400e;
        }
        .dark .bg-green-500 {
            background-color: #15803d;
        }
        .dark .hover\:bg-green-600:hover {
            background-color: #166534;
        }
        .dark .bg-gray-500 {
            background-color: #4b5563;
        }
        .dark .hover\:bg-gray-600:hover {
            background-color: #374151;
        }
        .dark .result-nav-btn, .dark .result-nav-btn-grid {
            background-color: #2563eb;
        }
        .dark .result-nav-btn:hover, .dark .result-nav-btn:active, .dark .result-nav-btn-grid:hover, .dark .result-nav-btn-grid:active {
            background-color: #1d4ed8;
        }
        .dark .result-nav-btn:disabled, .dark .result-nav-btn-grid:disabled {
            background-color: #4b5563;
        }
        .video-placeholder {
            width: 400px;
            height: 300px;
            background-color: #f0f0f0;
            display: flex;
            align-items: center;
            justify-content: center;
            cursor: pointer;
            margin-top: 10px;
            border-radius: 8px;
            border: 1px solid #ccc;
        }
        .play-icon {
            font-size: 40px;
            color: #007bff;
        }
        .video-loading {
            position: absolute;
            top: 50%;
            left: 50%;
            transform: translate(-50%, -50%);
            border: 4px solid #f3f3f3;
            border-top: 4px solid #3b82f6;
            border-radius: 50%;
            width: 40px;
            height: 40px;
            animation: spin 1s linear infinite;
        }
        @keyframes spin {
            0% { transform: translate(-50%, -50%) rotate(0deg); }
            100% { transform: translate(-50%, -50%) rotate(360deg); }
        }
    </style>

<script>
    // --- GEMINI AUTO-CAPTURE LISTENER ---
    // This function runs immediately after the quiz determines an answer is INCORRECT.
    function captureMistake(questionIndex, questionsData) {
        try {
            const item = questionsData[questionIndex];
            // Use the question text as a unique, stable identifier
            const uniqueId = 'srs_quiz_' + btoa(item.text.substring(0, 50)).replace(/=/g, ''); 

            // 1. Clean and simplify the explanation for storage
            let explanationText = item.explanation || item.correct_answer || "No explanation provided.";
            
            // Strip complex HTML (images, lists) and boilerplate text
            explanationText = explanationText.replace(/<img[^>]*>/g, "[IMAGE]").trim(); // Replace images with placeholder
            explanationText = explanationText.replace(/<p><strong>Ans\. [A-Z]\).*/i, "").trim(); // Remove the repeated Answer line
            explanationText = explanationText.replace(/<p><strong>Educational Objective:<\/strong>.*?<\/p>/gs, "").trim(); // Remove EO block
            explanationText = explanationText.replace(/@dams_new_robot/g, "");
            explanationText = explanationText.replace(/<\/?[^>]+(>|$)/g, " ").trim(); // Final strip of remaining tags

            // 2. Prepare card data
            const cardData = {
                text: item.text,
                answer: item.correct_answer,
                explanation: explanationText.substring(0, 500), // Keep explanations short
                nextReview: 0, // Due immediately
                reviews: 0,
                source: document.title.split('-')[0].trim() || 'Quiz'
            };

            // 3. Save to Local Storage (SRS Bank)
            localStorage.setItem(uniqueId, JSON.stringify(cardData));
            
            console.log(`ðŸ§  Captured Mistake #${questionIndex + 1} from ${document.title}`);

        } catch (e) {
            console.error("SRS Capture Failed:", e);
        }
    }
    // --- END GEMINI AUTO-CAPTURE LISTENER ---
</script>

</head>
<body class="bg-gray-100 font-sans transition-colors duration-300 min-h-screen overflow-y-auto">
<!-- Header Section -->
<header class="bg-blue-600 text-white p-4 shadow-lg">
<div class="container mx-auto">
<h1 class="text-2xl md:text-3xl font-bold header-text">Drugs For Dyslipidemia</h1>
<p class="mt-2 text-sm md:text-base subheader-text">
                8 Questions | 8 Total Marks | 18 min Duration | ~135.0 sec/question
            </p>
<button class="mt-2 bg-gray-200 text-gray-800 px-3 py-1 rounded-lg hover:bg-gray-300 transition dark:bg-gray-600 dark:text-white" id="theme-toggle">
                Toggle Dark Mode
            </button>
</div>
</header>
<!-- Instructions Section -->
<section class="container mx-auto p-4 md:p-6 section-transition" id="instructions">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-xl font-semibold mb-4">Instructions</h2>
<ul class="list-disc list-inside space-y-2 text-gray-700">
<li>This test contains 8 multiple choice questions.</li>
<li>Each question has only one correct answer.</li>
<li>You will have 18 minutes to complete the test.</li>
<li>Click or tap on an option to select your answer.</li>
<li>Use the "Mark for Review" button to revisit questions.</li>
<li>Navigate using Previous/Next buttons or the Questions Navigation panel.</li>
<li>Click "Submit" to finish and view results.</li>
<li>The test will auto-submit when time runs out.</li>
</ul>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="start-test">Start Test</button>


</div>
<div class="error-message hidden" id="error-message"></div>
</div>
</section>
<!-- Quiz Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="quiz">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<!-- Progress Bar -->
<div class="w-full bg-gray-200 rounded-full h-3 mb-4">
<div class="progress-bar h-3 rounded-full" id="progress-bar" style="width: 0%"></div>
</div>
<!-- Question Header -->
<div class="flex flex-col md:flex-row justify-between items-center mb-4">
<h2 class="text-lg font-semibold" id="question-number">Question <span>1</span> of 8</h2>
<p class="text-lg font-semibold mt-2 md:mt-0" id="timer">Time Remaining: <span>00:00</span></p>
</div>
<!-- Question Content -->
<div class="mb-6" id="question-content">
<p class="text-gray-800 mb-4" id="question-text"></p>
<div class="flex flex-wrap gap-4 mb-4" id="question-images"></div>
<div class="space-y-3" id="options"></div>
</div>
<!-- Navigation Buttons -->
<div class="flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition w-full md:w-auto" disabled="" id="previous-btn">Previous</button>
<button class="bg-yellow-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-yellow-400 transition w-full md:w-auto" id="mark-review">Mark for Review</button>
<button class="bg-blue-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="next-btn">Next</button>
<button class="bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full md:w-auto" id="nav-toggle">Questions Navigation</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="submit-test">Submit Test</button>
</div>
</div>
</section>
<!-- Results Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="results">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-2xl font-semibold mb-4">Drugs For Dyslipidemia - Results</h2>
<div class="grid grid-cols-1 md:grid-cols-2 gap-4 mb-6">
<p><strong>Correct:</strong> <span id="correct-count">0</span></p>
<p><strong>Wrong:</strong> <span id="wrong-count">0</span></p>
<p><strong>Unanswered:</strong> <span id="unanswered-count">0</span></p>
<p><strong>Marked for Review:</strong> <span id="marked-count">0</span></p>
</div>
<h3 class="text-lg font-semibold mb-4" id="result-question-number">Question <span>1</span> of 8</h3>
<div class="space-y-6" id="results-content"></div>
<div class="result-nav">
<button aria-label="Previous question result" class="result-nav-btn" disabled="" id="prev-result">Previous</button>
<button aria-label="Toggle results navigation panel" class="result-nav-btn" id="results-nav-toggle">Results Navigation</button>
<button aria-label="Next question result" class="result-nav-btn" id="next-result">Next</button>
</div>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="take-again">Take Again</button>
<button class="bg-gray-500 text-white px-6 py-2 rounded-lg hover:bg-gray-600 transition" id="review-test">Review Test</button>
</div>
</div>
</section>
<!-- Exit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="exit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Leave Test?</h2>
<p class="text-gray-700 mb-4">Your progress will be lost if you leave this page. Are you sure you want to exit?</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="continue-test">No, Continue</button>
<button class="bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition" id="exit-test">Yes, Exit</button>
</div>
</div>
</div>
<!-- Submit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="submit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Confirm Submission</h2>
<p class="text-gray-700 mb-2">You have attempted <span id="attempted-count">0</span> of 8 questions.</p>
<p class="text-gray-700 mb-4"><span id="unattempted-count">0</span> questions are unattempted.</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="cancel-submit">Cancel</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-green-600 transition" id="confirm-submit">Submit Test</button>
</div>
</div>
</div>
<!-- Quiz Navigation Panel -->
<div class="fixed inset-y-0 right-0 nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="nav-panel">
<h2 class="text-lg font-semibold mb-4">Questions Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-nav">Close</button>
</div>
<!-- Results Navigation Panel -->
<div class="fixed inset-y-0 right-0 results-nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="results-nav-panel">
<h2 class="text-lg font-semibold mb-4">Results Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="results-nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="results-nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-results-nav">Close</button>
</div>
<!-- JavaScript Logic -->
<script>
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog("Attempting to parse questions_json");
            questions = [{"text": "Metabolites of all statins have HMG-CoA reductase inhibitory activity except?", "options": [{"label": "A", "text": "Pravastatin", "correct": true}, {"label": "B", "text": "Rosuvastatin", "correct": false}, {"label": "C", "text": "Atorvastatin", "correct": false}, {"label": "D", "text": "Lovastatin", "correct": false}], "correct_answer": "A. Pravastatin", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Pravastatin it is used together with a proper diet to lower cholesterol and triglycerides (fat) in the blood. This medicine may help prevent or slow down medical problems, like atherosclerosis (hardening of the arteries), that are caused by fats clogging the blood vessels.</p>\n<p><strong>Highyeild:</strong></p><p>Pravastatin is hydrophilic and given in the active form. The LDLÂ¬CH lowering potency and efficacy is almost similar to lovastatin. An additional action of a decrease in plasma fibrinogen level has been observed. The tÂ½ is 1â€“3 hours The metabolites of all statins have some HMG-CoA reductase Inhibitory activity, except fluvastatin and pravastatin</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: B. Rosuvastatin is in a class of medications called HMG-CoA reductase inhibitors (statins). It works by slowing the production of cholesterol in the body to decrease the amount of cholesterol that may build up on the walls of the arteries and block blood flow to the heart, brain, and other parts of the body Option: C. Atorvastatin is in a class of medications called HMG-CoA reductase inhibitors (statins). It works by slowing the production of cholesterol in the body to decrease the amount of cholesterol that may build up on the walls of the arteries and block blood flow to the heart, brain, and other parts of the body Option: D. Lovastatin is used together with diet, weight loss, and exercise to reduce the risk of heart attack and stroke and to decrease the chance that heart surgery will be needed in people who have heart disease or who are at risk of developing heart disease</p>\n<p><strong>Table:</strong></p><p>#Mantra</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "All the following statins should be taken in the evening for the maximal effect on hepatic cholesterol synthesis except?", "options": [{"label": "A", "text": "Lovastatin", "correct": false}, {"label": "B", "text": "Simvastatin", "correct": false}, {"label": "C", "text": "Pravastatin", "correct": false}, {"label": "D", "text": "Atorvastatin", "correct": true}], "correct_answer": "D. Atorvastatin", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Atorvastatin</p>\n<p><strong>Highyeild:</strong></p><p>Because HMGÂ¬CoA reductase activity is maximal at midnight, all statins are administered at bedtime to obtain maximum effectiveness. However, this is not necessary for atorvastatin and rosuvastatin, which have long plasma tÂ½. The LDLÂ¬CH lowering potency and efficacy is almost similar to lovastatin. An additional action of a decrease in plasma fibrinogen level has been observed. The tÂ½ is 1â€“3 hours The metabolites of all statins have some HMG-CoA reductase Inhibitory activity, except fluvastatin and pravastatin</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A . Lovastatin is used together with diet, weight loss, and exercise to reduce the risk of heart attack and stroke and to decrease the chance that heart surgery will be needed in people who have heart disease or who are at risk of developing heart disease. Option: Simvastatin is in a class of medications called HMG-CoA reductase inhibitors (statins). It works by slowing the production of cholesterol in the body to decrease the amount of cholesterol that may build up on the walls of the arteries and block blood flow to the heart, brain, and other parts of the body Option: C. Pravastatin: it is used together with a proper diet to lower cholesterol and triglycerides (fat) in the blood. This medicine may help prevent or slow down medical problems, like atherosclerosis (hardening of the arteries), that are caused by fats clogging the blood vessels.</p>\n<p><strong>Table:</strong></p><p>#Mantra</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "When statins are administered with niacin, the myopathy probably is caused by?", "options": [{"label": "A", "text": "Decreased muscle-free fatty acids", "correct": false}, {"label": "B", "text": "Enhanced inhibition of skeletal muscle ubiquitin pathway", "correct": true}, {"label": "C", "text": "Pharmacokinetic interaction", "correct": false}, {"label": "D", "text": "None of the above", "correct": false}], "correct_answer": "B. Enhanced inhibition of skeletal muscle ubiquitin pathway", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Enhanced inhibition of skeletal muscle ubiquitin pathway Myopathy occurs when statins are administered with niacin</p>\n<p><strong>Highyeild:</strong></p><p>Muscle aches are the commonest (10%) side effect of statins. A rise in CPK levels occurs infrequently. Myopathy is the only serious reaction but is rare (< 1 per 1000). Few fatalities due to rhabdomyolysis are on record. Myopathy and liver injury are more common when nicotinic acid/gemfibrozil or CYP3A4 inhibitorâ€”ketoconazole/ erythromycin/cyclosporine/HIV protease inhibitor is given concurrently. Gemfibrozil inhibits the hepatic uptake of statins by the organic anion transporter OATP2 and should not be given with them. Fenofibrate interferes the least with statin uptake/metabolism and should be preferred for combining with them When statins are administered with niacin, the myopathy probably is caused by an enhanced inhibition of the skeletal muscle ubiquitin pathway (a Pharmacodynamic interaction) In 2016, the FDA withdrew approval for statin drug combinations containing fibrates or niacin The risk of myopathy due to statins is increased with niacin</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. Very rarely, statins can cause life-threatening muscle damage called rhabdomyolysis. Rhabdomyolysis can cause severe muscle pain, liver damage, kidney failure, and death. The risk of very serious side effects is extremely low and calculated in a few cases per million people taking statins. Option: B. mechanism by which statin treatment can make skeletal muscles susceptible to myopathyâ€”dissociation of the FK506 binding protein (FKBP12) from the sarcoplasmic reticulum (SR) Ca 2+ release channel, the ryanodine receptor 1 (RyR1), which is accompanied by numerous spontaneous Ca 2+ release events Option: C. The interaction with simvastatin seems mainly driven by CYP3A4 inhibition at the intestinal level, whereas the interaction with atorvastatin is more due to hepatic CYP3A4 inhibition. The interaction of CYP3A4 inhibitor with simvastatin has been more pronounced compared with atorvastatin</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "The Statin of choice in severe renal dysfunction patients is", "options": [{"label": "A", "text": "Rosuvastatin", "correct": false}, {"label": "B", "text": "Simvastatin", "correct": false}, {"label": "C", "text": "Atorvastatin", "correct": true}, {"label": "D", "text": "Lovastatin", "correct": false}], "correct_answer": "C. Atorvastatin", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Atorvastatin This is a high efficacy and one of the most commonly used statins capable of lowering LDLÂ¬CH. At this dose, a greater reduction in TGs is noted if the same was raised at baseline. Atorvastatin has a much longer plasma tÂ½ of 14â€“18 hr and has additional antioxidant properties. Statin of choice for patients with severe renal dysfunction as it does not require dose adjustment. In liver disease, Rosuvastatin is preferred</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Statin causing maximum reduction of LDL is:", "options": [{"label": "A", "text": "Simvastatin", "correct": false}, {"label": "B", "text": "Rosuvastatin", "correct": true}, {"label": "C", "text": "Pravastatin", "correct": false}, {"label": "D", "text": "Pitavastatin", "correct": false}], "correct_answer": "B. Rosuvastatin", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Rosuvastatin Rosuvastatin belongs to a group of medicines called statins. It is used to lower cholesterol and to reduce the risk of heart disease. Cholesterol is a fatty substance that builds up in your blood vessels and causes narrowing, which may lead to a heart attack or stroke. Statin causing maximum reduction of LDL (51-55% is Rosuvastatin (20mg & 40mg) and atorvastatin</p>\n<p><strong>Highyeild:</strong></p><p>Rosuvastatin: Limited drug-drug interactions No clinically significant interactions seen or expected with: Fluconazole / Ketoconazole / Itracnoazole Fenofibrate Digoxin Drugs mediated by cytochrome P450 metabolism Interactions with limited clinical significance: Oral contraceptive pill - â†‘ ethinyl oestradiol and norgestrel levels Antacid - â†“ 50% rosuvastatin levels Erythromycin - â†“ 20-30% rosuvastatin plasma levels Warfarin - â†‘ INR Interactions resulting in not recommended for use: Gemfibrozil - 2x increase in resÄ±nÄ±astatin plasma levels Interactions resulting is contraindication to concomitant use: Cyclosporin - 7x increase in rosuvastatin plasma levels</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 65-year-old patient was admitted to the hospital with features of muscle pain, fatigue, and dark-colored urine after a general physician started him on medication for his sore throat. He was taking tenololtin for hyperlipidemia and atenolol for hypertension. Lab investigations showed urine dipstick positive for blood but no RBCs in urine microscopy. His serum creatine kinase enzyme is raised. What medication was added by the general physician?", "options": [{"label": "A", "text": "Amoxicillin", "correct": false}, {"label": "B", "text": "Levofloxacin", "correct": false}, {"label": "C", "text": "Azithromycin", "correct": false}, {"label": "D", "text": "Erythromycin", "correct": true}], "correct_answer": "D. Erythromycin", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Erythromycin</p>\n<p><strong>Highyeild:</strong></p><p>Atorvastatin-induced myopathy: This is a case of atorvastatin-induced myopathy and rhabdomyolysis, presenting with myoglobinuria and raised CPK levels Muscle aches are the commonest (10%) side effect. A rise in CPK levels occurs infrequently. Myopathy is the only serious reaction but is rare (< 1 per 1000). Few fatalities due to rhabdomyolysis are on record. Myopathy and liver injury are more common when nicotinic acid/ gemfibrozil or CYP3A4 inhibitorâ€”ketoconazole/erythroid my cin/cyclosporine/HIV protease inhibitor is given concurrently. So the correct answer is erythromycin</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which one of the following drugs is most likely to cause impaired glucose tolerance?", "options": [{"label": "A", "text": "Bezafibrate", "correct": false}, {"label": "B", "text": "Simvastatin", "correct": false}, {"label": "C", "text": "Nicotinic acid", "correct": true}, {"label": "D", "text": "Cholestyramine", "correct": false}], "correct_answer": "C. Nicotinic acid", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Nicotinic acid</p>\n<p><strong>Highyeild:</strong></p><p>Nicotinic acid (niacin) Nicotinic acid inhibits intracellular lipolysis by lipases in adipocytes and decreases the flow of free fatty acids (FFAs) from adipose tissue to the liver. This reduces the availability of FFAs for the production of TGs and VLDL in the liver. Direct inhibition of hepatocyte TG synthesis is also possible. Indirectly, the VLDL degradation products IDL and LDL are also reduced, but no direct effect on CH and bile acid metabolism has been found. In patients with diabetes mellitus, niacin should be used cautiously because niacin-induced insulin resistance can cause severe hyperglycemia</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: D. Cholestyramine i s used to lower high cholesterol level in the blood it remove substances called bile acids from your body. Option: A. Bezafibrate - A fibrate drug used as a lipid-lowering agent to treat hyperlipidemia. Option: B. Simvastatin- using acetyl-COA as a substrate, mevalonic acid is formed and subsequent reactions lead to the formation of cholesterol</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following is a PCSK9 inhibitor?", "options": [{"label": "A", "text": "Reslizumab", "correct": false}, {"label": "B", "text": "Brodalumab", "correct": false}, {"label": "C", "text": "Alirocumab", "correct": true}, {"label": "D", "text": "Ixekizumab", "correct": false}], "correct_answer": "C. Alirocumab", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Alirocumab Anti- PCSK-9 mab s: Inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9). PCSK9 is a protein that targets LDL receptors for degradation and thereby reduces the liver